GH Axis
CJC-1295 (No DAC)
Modified GRF (1-29) · Mod GRF 1-29
Tetra-substituted GHRH(1-29) analogue for pulsatile GH-release research.
2 mg5 mg10 mg
Sermorelin Acetate
Also known as: GHRH (1-29) NH2 · GRF 1-29 · Geref
Growth Hormone Axis In stock Box of 10 vials 2 references
The native 29-residue active fragment of GHRH.
Available sizes
| SKU | Per vial | Pack | |
|---|---|---|---|
| SMO5 | 5 mg | 10 vials / box | |
| SMO10 | 10 mg | 10 vials / box |
Order Sermorelin Acetate
Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.
Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.
Sermorelin is the acetate salt of GHRH(1-29)-NH2, the shortest fragment of growth-hormone-releasing hormone that retains full biological activity 2. It stimulates GH secretion from pituitary somatotrophs via the GHRH receptor.
Sermorelin has been used clinically both as a diagnostic agent for GH-secretory capacity and as a treatment in children with GH deficiency; a review of its use summarises the clinical pharmacology 1.
At a glance
- Native GHRH (1-29) — reference GHRH-receptor agonist
- Clinically characterised in GH-deficiency diagnosis
- 5 mg and 10 mg vials
Research use only. All products are sold strictly for laboratory research and development purposes. They are not intended for human or veterinary use, diagnosis, treatment, cure or prevention of any disease. Not for human consumption. Summaries above describe published findings in laboratory and clinical research models and do not constitute claims about this product.
- Form
- Lyophilized powder
- Purity
- HPLC-verified — Certificate of Analysis available on request
- Pack size
- Box of 10 vials
- Storage
- Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.
- Sequence
- Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
- Formula
- C149H246N44O42S
- Mol. weight
- 3357.9 g/mol
- CAS No.
- 86168-78-7
Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.
- Prakash A, Goa KL Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
- Grossman A, Savage MO, Besser GM Growth hormone releasing hormone. Clin Endocrinol Metab. 1986;15(3):607-27.
Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.
Related
Often ordered together
GH Axis
Tesamorelin
TH9507 · Egrifta
Stabilised GHRH analogue with phase 3 evidence for visceral-fat reduction.
2 mg5 mg10 mg15 mg20 mg
GH Axis
GHRP-6 Acetate
Growth hormone-releasing hexapeptide · SKF-110679
The original synthetic GH-releasing hexapeptide that led to the discovery of ghrelin.
5 mg10 mg